Idorsia Ltd. (IDRSF)
5.38
0.00 (0.00%)
USD |
OTCM |
Oct 21, 16:00
Idorsia Net Income (Annual) : -134.49M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -134.49M |
| December 31, 2024 | -299.50M |
| December 31, 2023 | -331.52M |
| December 31, 2022 | -866.85M |
| December 31, 2021 | -694.10M |
| Date | Value |
|---|---|
| December 31, 2020 | -474.23M |
| December 31, 2019 | -497.74M |
| December 31, 2018 | -395.96M |
| December 31, 2017 | -15.53M |
| December 31, 2016 | -341.76M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Basilea Pharmaceutica AG | 48.45M |
| Santhera Pharmaceuticals Holding AG | -59.29M |
| BeOne Medicines Ltd. | 287.69M |
| AC Immune SA | -84.83M |
| CRISPR Therapeutics AG | -581.60M |